Coactivator selective regulation of androgen receptor activity

Steroids

Volumn 74, Issue 8, 2009, Pages 669-674

  Agoulnik, Irina U ^a   Weigel, Nancy L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Androgen receptor; Cyproterone acetate; LNCaP; RAC3; SRA; SRC 3

Indexed keywords

ANDROGEN RECEPTOR; CYPROTERONE ACETATE; LIGAND; PROSTATE SPECIFIC ANTIGEN; PROTEIN DERIVATIVE; PROTEIN P160; RAC3 PROTEIN; SMALL INTERFERING RNA; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN LNCAP; CHROMATIN; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CYPROTERONE ACETATE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE ACETYLTRANSFERASES; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, UNTRANSLATED; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 67349225032     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2009.02.007     Document Type: Article

References (22)

1. Li R., Wheeler T., Dai H., Frolov A., Thompson T., and Ayala G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 28 7 (2004) 928-934
2. Chen C.D., Welsbie D.S., Tran C., Baek S.H., Chen R., Vessella R., et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 10 1 (2004) 33-39
3. Heemers H.V., and Tindall D.J. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr Rev 28 7 (2007) 778-808
4. Yeh S., Miyamoto H., Shima H., and Chang C. From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA 95 10 (1998) 5527-5532
5. Agoulnik I.U., Vaid A., Bingman III W.E., Erdeme H., Frolov A., Smith C.L., et al. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res 65 17 (2005) 7959-7967
6. Agoulnik I.U., Vaid A., Nakka M., Alvarado M., Bingman III W.E., Erdem H., et al. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 66 21 (2006) 10594-10602
7. Zhou H.J., Yan J., Luo W., Ayala G., Lin S.H., Erdem H., et al. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res 65 17 (2005) 7976-7983
8. Yan J., Yu C.T., Ozen M., Ittmann M., Tsai S.Y., and Tsai M.J. Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway. Cancer Res 66 22 (2006) 11039-11046
9. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., et al. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97 1 (1999) 17-27
10. Lanz R.B., Chua S.S., Barron N., Soder B.M., DeMayo F., and O'Malley B.W. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol Cell Biol 23 20 (2003) 7163-7176
11. Agoulnik I.U., Krause W.C., Bingman III W.E., Rahman H.T., Amrikachi M., Ayala G.E., et al. Repressors of androgen and progesterone receptor action. J Biol Chem 278 33 (2003) 31136-31148
12. Nazareth L.V., and Weigel N.L. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 271 33 (1996) 19900-19907
13. Onate S.A., Tsai S.Y., Tsai M.J., and O'Malley B.W. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270 5240 (1995) 1354-1357
14. Gillatt D. Antiandrogen treatments in locally advanced prostate cancer: are they all the same?. J Cancer Res Clin Oncol 132 Suppl. 1 (2006) S17-26
15. Miyamoto H., Yeh S., Wilding G., and Chang C. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA 95 13 (1998) 7379-7384
16. Hatchell E.C., Colley S.M., Beveridge D.J., Epis M.R., Stuart L.M., Giles K.M., et al. SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. Mol Cell 22 5 (2006) 657-668
17. Watanabe M., Yanagisawa J., Kitagawa H., Takeyama K., Ogawa S., Arao Y., et al. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. Embo J 20 6 (2001) 1341-1352
18. Shi Y., Downes M., Xie W., Kao H.Y., Ordentlich P., Tsai C.C., et al. Sharp, an inducible cofactor that integrates nuclear receptor repression and activation. Genes Dev 15 9 (2001) 1140-1151
19. Kawashima H., Takano H., Sugita S., Takahara Y., Sugimura K., and Nakatani T. A novel steroid receptor co-activator protein (SRAP) as an alternative form of steroid receptor RNA-activator gene: expression in prostate cancer cells and enhancement of androgen receptor activity. Biochem J 369 Pt 1 (2003) 163-171
20. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310 5748 (2005) 644-648
21. Wang J., Cai Y., Ren C., and Ittmann M. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 66 17 (2006) 8347-8351
22. Agoulnik I.U., Bingman III W.E., Nakka M., Li W., Wang Q., Liu X.S., et al. Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase. Mol Endocrinol 22 11 (2008) 2420-2432